Skip to content

Neurogrit Gold Alleviates Motor, Behavioural, and oxidative stress deficits in the MPTP-induced Drosophila melanogaster model of Parkinson's disease.

Sep 2026 · Brain Research · pp. 150542 · 0 citations · 71 references
Medicine

TL;DR

Preclinical evidence is provided on the neuroprotective potential of Ayurvedic polyherbal formulation, Neurogrit Gold, positioning it as a promising natural candidate for further investigation in advanced animal models of Parkinson's disease.

Abstract

Parkinson's disease is characterized by degeneration of dopaminergic neurons in the midbrain, primarily affecting the substantia nigra, while conventional treatments provide only symptomatic relief with adverse long-term effects. In contrast, herbal drugs exhibit multi-targeted neuroprotective properties, potentially addressing oxidative stress, neuro-inflammation, and neuronal apoptosis with better tolerability. Present study explores the neuroprotective potential of Ayurvedic polyherbal formulation, Neurogrit Gold (NG) in a Drosophila melanogaster model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). Phytometabolite profiling of NG by HPLC and GC-FID identified several phytometabolites and fatty acids, including Cordifolioside, Magnoflorine, and Palmatine, Palmitic acid, Stearic acid, Oleic acid, Linoleic acid and γ-Linolenic acid. Present study demonstrated that NG enhanced climbing activity, improved cognition and food sensing behaviour in Drosophila exposed to MPTP. Additionally, NG prevented MPTP-induced phenotypic alterations and locomotory deficits in Drosophila larvae, as evidenced by increased larval volume and crawling activity. NG prevented MPTP-induced reduction in brain size of Drosophila larvae and prevented the impairment in their ability to locate food and preserved self-righting behaviour. Moreover, NG enhanced anti-oxidant defence mechanisms, indicated by increased GSH levels, SOD activity while suppressing ROS levels in Drosophila heads. These NG-mediated beneficial effects were found to be associated with modulation in gene expression of parkin, Tyrosine hydroxylase (TH) and Dopamine transporter (DAT). Collectively, this study provides preclinical evidence on the neuroprotective potential of Neurogrit Gold, positioning it as a promising natural candidate for further investigation in advanced animal models of Parkinson's disease.

View source

Similar papers

Sep 2026

AA-2βG attenuates nigrostriatal degeneration and related dopaminergic, redox, and inflammatory alterations in experimental parkinsonism.

Parkinson's disease (PD) is characterized by progressive nigrostriatal degeneration, dopamine depletion, and interactions among neuronal vulnerability, oxidative imbalance, and neuroinflammatory responses. AA-2βG is a chemically stable ascorbate derivative; however, its protective profile in experimental parkinsonism r...

Wei-Lei Ma, Le-Ping Yan, Jian-Hua Ding et al. · 0 citations
Open access Aug 2026

PT320, a GLP-1 receptor agonist, mitigates nucleus accumbens–associated depression- and anxiety-like behaviors in MitoPark mice of Parkinson's disease

By restoring neurotrophic signaling and dopaminergic function, PT320 represents a promising therapeutic strategy for PD-related anxiety and depression by restoring neurotrophic signaling and dopaminergic function in the nucleus accumbens.

Kuan-Yin Tseng, Tung-Tai Kuo, P. Chang et al. · 0 citations
Open access Jun 2026

Therapeutic potential of nasal kisspeptin-54 for reducing α-synuclein accumulation and restoring hippocampal synaptic plasticity in a 6-hydroxydopamine-induced rat model of Parkinson’s disease

It is indicated that nasal KP-54 administration exerts neurorestorative effects in a 6-OHDA rat model of PD by preserving dopaminergic neurons, improving synaptic function, and attenuating pathological α-syn aggregation.

Ayşegül Gemici Sinen, E. Savran, Okyanus Bora Güleç et al. · 0 citations
Open access Sep 2026

Gomisin N ameliorates autophagy-neuroinflammation imbalance in Parkinson's disease models via modulating the ATG16L1/NLRP3 axis.

GN is a brain-penetrant preclinical candidate that links ATG16L1-dependent autophagy with α-synuclein clearance and NLRP3 inflammasome suppression in PD models and completely abrogated the neuroprotective and anti-inflammatory effects of GN both in vitro and in vivo.

Cheng-Fu Su, Zhi-Qiang Deng, Ka-Yee Ying et al. · 0 citations
Oct 2026

Norepinephrine modulates the microglial response and protects against MPTP-induced Parkinson's disease pathology through regulation of the PI3K/AKT/mTOR pathway.

AIMS Norepinephrine (NE) deficiency is an early and prominent feature of Parkinson's disease (PD), but its specific contributions to pathogenesis have not been fully elucidated. This study aims to determine whether NE exerts neuroprotective effects in PD models through the modulation of autophagy and microglial activat...

Huan Yin, Dan Zhao, Yun-Fu Wang · 0 citations
Aug 2026

Astragalin confers coordinated neuroprotection in Parkinson's disease models through modulation of neurotrophic, anti-inflammatory, and synuclein-related pathways.

The natural flavonoid Astragalin concurrently addresses three core pathological processes in PD, namely dopaminergic neuron degeneration, α-synucleinopathy, and neuroinflammation, through coordinated modulation of interconnected molecular pathways.

Jun Wang, Jie-Yu He, Qin Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.